Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 517 to 519 of 519 entries
Sorted by: Best Match Show Resources per page
What Kind of Intervention Is Effective for Improving Subjective Well-Being Among Workers? A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Frontiers in psychology

Sakuraya A, Imamura K, Watanabe K, Asai Y, Ando E, Eguchi H, Nishida N, Kobayashi Y, Arima H, Iwanaga M, Otsuka Y, Sasaki N, Inoue A, Inoue R, Tsuno K, Hino A, Shimazu A, Tsutsumi A, Kawakami N.
PMID: 33281653
Front Psychol. 2020 Nov 13;11:528656. doi: 10.3389/fpsyg.2020.528656. eCollection 2020.

No abstract available.

Cite
Sakuraya A, Imamura K, Watanabe K, et al. What Kind of Intervention Is Effective for Improving Subjective Well-Being Among Workers? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Psychol. 2020;11:528656doi: 10.3389/fpsyg.2020.528656.
Sakuraya, A., Imamura, K., Watanabe, K., Asai, Y., Ando, E., Eguchi, H., Nishida, N., Kobayashi, Y., Arima, H., Iwanaga, M., Otsuka, Y., Sasaki, N., Inoue, A., Inoue, R., Tsuno, K., Hino, A., Shimazu, A., Tsutsumi, A., & Kawakami, N. (2020). What Kind of Intervention Is Effective for Improving Subjective Well-Being Among Workers? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in psychology, 11528656. https://doi.org/10.3389/fpsyg.2020.528656
Sakuraya, Asuka, et al. "What Kind of Intervention Is Effective for Improving Subjective Well-Being Among Workers? A Systematic Review and Meta-Analysis of Randomized Controlled Trials." Frontiers in psychology vol. 11 (2020): 528656. doi: https://doi.org/10.3389/fpsyg.2020.528656
Sakuraya A, Imamura K, Watanabe K, Asai Y, Ando E, Eguchi H, Nishida N, Kobayashi Y, Arima H, Iwanaga M, Otsuka Y, Sasaki N, Inoue A, Inoue R, Tsuno K, Hino A, Shimazu A, Tsutsumi A, Kawakami N. What Kind of Intervention Is Effective for Improving Subjective Well-Being Among Workers? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Psychol. 2020 Nov 13;11:528656. doi: 10.3389/fpsyg.2020.528656. eCollection 2020. PMID: 33281653; PMCID: PMC7691289.
Copy Download .nbib Format: NLM
Enhanced Malignant Phenotypes of Glioblastoma Cells Surviving NPe6-Mediated Photodynamic Therapy are Regulated via ERK1/2 Activation.

Cancers

Kobayashi T, Miyazaki M, Sasaki N, Yamamuro S, Uchida E, Kawauchi D, Takahashi M, Otsuka Y, Kumagai K, Takeuchi S, Toyooka T, Otani N, Wada K, Narita Y, Yamaguchi H, Muragaki Y, Kawamata T, Mori K, Ichimura K, Tomiyama A.
PMID: 33291680
Cancers (Basel). 2020 Dec 04;12(12). doi: 10.3390/cancers12123641.

To manage refractory and invasive glioblastomas (GBM)s, photodynamic therapy (PDT) using talaporfin sodium (NPe6) (NPe6-PDT) was recently approved in clinical practice. However, the molecular machineries regulating resistance against NPe6-PDT in GBMs and mechanisms underlying the changes in GBM phenotypes...

Cite
Kobayashi T, Miyazaki M, Sasaki N, et al. Enhanced Malignant Phenotypes of Glioblastoma Cells Surviving NPe6-Mediated Photodynamic Therapy are Regulated via ERK1/2 Activation. Cancers (Basel). 2020;12(12)doi: 10.3390/cancers12123641.
Kobayashi, T., Miyazaki, M., Sasaki, N., Yamamuro, S., Uchida, E., Kawauchi, D., Takahashi, M., Otsuka, Y., Kumagai, K., Takeuchi, S., Toyooka, T., Otani, N., Wada, K., Narita, Y., Yamaguchi, H., Muragaki, Y., Kawamata, T., Mori, K., Ichimura, K., & Tomiyama, A. (2020). Enhanced Malignant Phenotypes of Glioblastoma Cells Surviving NPe6-Mediated Photodynamic Therapy are Regulated via ERK1/2 Activation. Cancers, 12(12), . https://doi.org/10.3390/cancers12123641
Kobayashi, Tatsuya, et al. "Enhanced Malignant Phenotypes of Glioblastoma Cells Surviving NPe6-Mediated Photodynamic Therapy are Regulated via ERK1/2 Activation." Cancers vol. 12,12 (2020). doi: https://doi.org/10.3390/cancers12123641
Kobayashi T, Miyazaki M, Sasaki N, Yamamuro S, Uchida E, Kawauchi D, Takahashi M, Otsuka Y, Kumagai K, Takeuchi S, Toyooka T, Otani N, Wada K, Narita Y, Yamaguchi H, Muragaki Y, Kawamata T, Mori K, Ichimura K, Tomiyama A. Enhanced Malignant Phenotypes of Glioblastoma Cells Surviving NPe6-Mediated Photodynamic Therapy are Regulated via ERK1/2 Activation. Cancers (Basel). 2020 Dec 04;12(12). doi: 10.3390/cancers12123641. PMID: 33291680; PMCID: PMC7761910.
Copy Download .nbib Format: NLM
Clinical characteristics and drug susceptibility patterns of Corynebacterium species in bacteremic patients with hematological disorders.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Abe M, Kimura M, Maruyama H, Watari T, Ogura S, Takagi S, Uchida N, Otsuka Y, Taniguchi S, Araoka H.
PMID: 33895886
Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2095-2104. doi: 10.1007/s10096-021-04257-8. Epub 2021 Apr 24.

The aim of this study was to clarify the clinical and microbiological characteristics of Corynebacterium bacteremia in hematological patients. We retrospectively reviewed the medical records of patients with Corynebacterium bacteremia from April 2013 to June 2018. The causative Corynebacterium...

Cite
Abe M, Kimura M, Maruyama H, et al. Clinical characteristics and drug susceptibility patterns of Corynebacterium species in bacteremic patients with hematological disorders. Eur J Clin Microbiol Infect Dis. 2021;40(10):2095-2104doi: 10.1007/s10096-021-04257-8.
Abe, M., Kimura, M., Maruyama, H., Watari, T., Ogura, S., Takagi, S., Uchida, N., Otsuka, Y., Taniguchi, S., & Araoka, H. (2021). Clinical characteristics and drug susceptibility patterns of Corynebacterium species in bacteremic patients with hematological disorders. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 40(10), 2095-2104. https://doi.org/10.1007/s10096-021-04257-8
Abe, Masahiro, et al. "Clinical characteristics and drug susceptibility patterns of Corynebacterium species in bacteremic patients with hematological disorders." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. 40,10 (2021): 2095-2104. doi: https://doi.org/10.1007/s10096-021-04257-8
Abe M, Kimura M, Maruyama H, Watari T, Ogura S, Takagi S, Uchida N, Otsuka Y, Taniguchi S, Araoka H. Clinical characteristics and drug susceptibility patterns of Corynebacterium species in bacteremic patients with hematological disorders. Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2095-2104. doi: 10.1007/s10096-021-04257-8. Epub 2021 Apr 24. PMID: 33895886.
Copy Download .nbib Format: NLM
Showing 517 to 519 of 519 entries